Norris Medicines - NORRIS, 524414 corporate action history

See all forthcoming Bonus and Splits

See all forthcoming Bonus and Splits

Ex-Date	Purpose	Notes
14 Feb 2026	Quarterly Results	-
14 Nov 2025	Quarterly Results	-
14 Aug 2025	Quarterly Results	-
28 May 2025	Audited Results	-
13 Feb 2025	Quarterly Results & Others	Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters.
14 Nov 2024	Quarterly Results	-
14 Aug 2024	Quarterly Results	-
29 May 2024	Audited Results	-
14 Feb 2024	Quarterly Results	-
29 Dec 2023	Others	Inter alia : 1. To Consider and approve Authorized Signatory for Bank Operations. 2. To Consider and recommend Mr. Vimal Shah as a Director of the Company subject to Members approval.

See all Rights History for Norris Medicines